• Zenith Therapeutics AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-270.3.016.466-5
    Sector: Research and development

    Registered since

    3 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    166'500

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Zenith Therapeutics AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Zenith Therapeutics AG

    • Zenith Therapeutics AG with its legal headquarters in Basel is a Company limited by shares (AG) from the sector «Research and development». Zenith Therapeutics AG is active.
    • The management of the company Zenith Therapeutics AG consists of 6 persons.
    • Under «Notifications» you will find all commercial register changes, the most recent one was made on 02.12.2025.
    • In the commercial register the company Zenith Therapeutics AG is registered under the UID CHE-372.198.173.
    • Next to the company Zenith Therapeutics AG there are 21 other active companies with an identical address. These include: AlpENa Biosciences AG, Basel Tourismus, Cimeio Therapeutics AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien. Die Gesellschaft kann Tochtergesellschaften und Zweigniederlassungen errichten und sich an anderen Unternehmen beteiligen. Die Gesellschaft kann Grundstücke und Im- materialgüterrechte erwerben, halten und veräussern. Die Gesellschaft kann auch alle kommerziellen, finanziellen und anderen Tätigkeiten ausüben, welche mit dem Zweck der Gesellschaft direkt oder indirekt im Zusammenhang stehen.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 31.07.2025

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Zenith Therapeutics SA
    • Zenith Therapeutics Ltd
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Zenith Therapeutics AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 251202/2025 - 02.12.2025
    Categories: Change in management

    Publication number: HR02-1006500364, Commercial Registry Office Basel-Stadt, (270)

    Berichtigung des im SHAB Nr. 1'006'492'622 vom24.11.2025 publizierten TR-Eintrags Nr. 8'095 vom 19.11.2025 Zenith Therapeutics AG, in Basel, CHE-372.198.173, Aktiengesellschaft (SHAB Nr. 227 vom 24.11.2025, Publ. 1006492622).

    Eingetragene Personen neu oder mutierend:
    Essig, Sebastian, deutscher Staatsangehöriger, in Sinsheim (DE), mit Kollektivunterschrift zu zweien [nicht: in Sinsheim (FR)].

    SOGC 251124/2025 - 24.11.2025
    Categories: Change in management

    Publication number: HR02-1006492622, Commercial Registry Office Basel-Stadt, (270)

    Zenith Therapeutics AG, in Basel, CHE-372.198.173, Aktiengesellschaft (SHAB Nr. 146 vom 31.07.2025, Publ. 1006398883).

    Eingetragene Personen neu oder mutierend:
    Essig, Sebastian, deutscher Staatsangehöriger, in Sinsheim (FR), mit Kollektivunterschrift zu zweien;
    Thoma, Claudio, von Kaltbrunn, in Huningue (FR), mit Kollektivunterschrift zu zweien.

    SOGC 250731/2025 - 31.07.2025
    Categories: Change of auditors

    Publication number: HR02-1006398883, Commercial Registry Office Basel-Stadt, (270)

    Zenith Therapeutics AG, in Basel, CHE-372.198.173, Aktiengesellschaft (SHAB Nr. 64 vom 02.04.2025, Publ. 1006298177). [gestrichen: Gemäss Erklärung vom 17.03.2022 wurde auf die eingeschränkte Revision verzichtet.].

    Eingetragene Personen neu oder mutierend:
    Ernst & Young AG (CHE-105.932.265) [ CH-270.3.012.140-6], in Basel, Revisionsstelle.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm